These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 5565346

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The influence of orciprenaline on circulation in the lung].
    Daum S, Stiksa J, Nikodýmová L, Petrle A, Svorcik C.
    Arzneimittelforschung; 1967 May; 17(5):565-8. PubMed ID: 5631585
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [New beta-adrenergic receptor stimulators in the symptomatic treatment of asthma and chronic obstructive bronchial diseases].
    Van Der Straeten M, Lamont H, Pauwels R, Tasson J.
    Acta Tuberc Pneumol Belg; 1974 May; 65(3-4):384-94. PubMed ID: 4156900
    [No Abstract] [Full Text] [Related]

  • 8. The bronchodilator effects of orciprenaline and salbutamol. A double-blind study.
    Racoveanu C, Stanescu DC, Manicatide M, Stroescu V.
    Postgrad Med J; 1971 Mar; 47():Suppl:83-6. PubMed ID: 4929399
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical experiences with a new drug association with anti-asthmatic action].
    Martelli A.
    Clin Ter; 1967 Jun 30; 41(6):529-44. PubMed ID: 4387419
    [No Abstract] [Full Text] [Related]

  • 11. The combined action of broncholytic agents in asthmatic patients: orciprenaline, isoprenaline, and ephedrine.
    Muittari A, Mattila MJ, Tiitinen H.
    Ann Med Intern Fenn; 1968 Jun 30; 57(1):31-5. PubMed ID: 4882181
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Comparative evaluation of the bronchodilator effects and cardiovascular effects of 3 beta adrenergic stimulants in bronchial asthma--comparison of isoproterenol, metaproterenol and salbutamol].
    Matsumoto S, Tanaka Y, Wagatsuma Y, Miura R, Umezu A.
    Arerugi; 1971 Aug 30; 20(8):599-609. PubMed ID: 4398383
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Salbutamol as a beta-adrenergic stimulator in bronchospastic pulmonary conditions].
    Dano P, Falholt W.
    Ugeskr Laeger; 1971 Apr 16; 133(15):685-8. PubMed ID: 4396922
    [No Abstract] [Full Text] [Related]

  • 16. [Efficacy in the bronchitic syndrome of an orciprenaline-calcium iodide combination].
    Tolva D, Benati E.
    Minerva Med; 1965 Oct 24; 56(85):3622-5. PubMed ID: 5841669
    [No Abstract] [Full Text] [Related]

  • 17. Bronchodilators.
    Cochrane GM.
    Practitioner; 1979 Oct 24; 223(1336):489-98. PubMed ID: 523401
    [No Abstract] [Full Text] [Related]

  • 18. A crossover comparison of isoproterenol, metaproterenol and isoetharine by spirometric determinations.
    Howard LA, Coleman M.
    Ann Allergy; 1967 Sep 24; 25(9):512-9. PubMed ID: 4861327
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sympathomimetic drugs in acute viral bronchiolitis. Their effect on pulmonary resistance.
    Phelan PD, Williams HE.
    Pediatrics; 1969 Oct 24; 44(4):493-7. PubMed ID: 5346627
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.